Monika Barbarić
University of Zagreb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monika Barbarić.
Journal of Ethnopharmacology | 2011
Monika Barbarić; Katarina Mišković; Mirza Bojić; Mirela Baus Lončar; Asja Smolčić-Bubalo; Željko Debeljak; Marica Medić-Šarić
ETHNOPHARMACOLOGICAL RELEVANCE Propolis is a resinous hive product collected by honeybees from various plant sources. It is widely used in traditional medicine and is reported to have a broad spectrum of pharmacological effects (antibacterial, antihepatoxic, antioxidative, anti-inflammatory, etc.). Thus the aim of this study was to assess cytotoxic effect of various ethanol propolis extractions on the cervical tumor cell line (HeLa) and compare it with their phenolic acids and flavonoids composition. MATERIALS AND METHODS Twenty samples of raw propolis were collected from 17 localities of Croatia (I-XVII), 2 of Bosnia and Hercegovina (XVIII, XIX) and 1 of Macedonia (XX). Reverse phase HPLC was used to determine the chemical composition of polyphenols. Biological experiments were carried out in vitro on cervix adenocarcinoma cell line (HeLa). RESULTS Phenolic acids (ferulic acid, p-coumaric acid, caffeic acid) and flavonoids (tectochrysin, galangin, pinocembrin, pinocembrin-7-methylether, chrysin, apigenin, kaempferol, quercetin) have been determined using HPLC analysis in 20 ethanolic propolis extracts. All samples contain tectochrysin in ranges of 0.1988 mg/g (XVIII) to 1.2004 mg/g (III), while caffeic acid and quercetin have not been found. Flavonoid that is most abundant is galangin in ranges from 0.3706 mg/g (XVII) to 47.4879 mg/g (IX). The samples of propolis numbers I, VI and X applied in the investigated concentration range manifested significant reduction of cell growth. GI(50) value as indicator of cytotoxicity among propolis samples showed that propolis number VII is the most effective (GI(50) =76 μg/ml) followed by propolis nos. XV, XVIII and I. CONCLUSION Antiproliferative and cytotoxic effect of propolis on the HeLa cells is not correlating with the concentration of particular components but on establishing the possible synergistic antiproliferative activity of individual phenolic acid and flavonoids. Differences in the chemical composition lead to diversity in biological activity of propolis samples.
Molecules | 2011
Marijana Zovko Končić; Monika Barbarić; Ivana Perković; Branka Zorc
Reactive oxygen species, along with reactive nitrogen species, may play an important role in the pathogenesis and progress of many diseases, including cancer, diabetes and sickle cell disease. It has been postulated that hydroxyurea, one of the main treatments in sickle cell disease, achieves its activity partly also through its antioxidant properties. A series of hydroxyurea derivatives of L- and D-amino acid amides and cycloalkyl-N-aryl-hydroxamic acids was synthesized and investigated for their radical scavenging activity, chelating properties and antioxidant activity. All the compounds showed exceptional antiradical activities. For example, free radical scavenging activities of investigated hydroxyureas were higher than the activity of standard antioxidant, butylated hydroxyanisole (BHA). Moreover, most of the investigated hydroxamic acids were stronger Fe2+ ion chelators than quercetin. In addition, the investigated compounds, especially hydroxamic acids, were proven to be excellent antioxidants. They were as effective as BHA in inhibiting β-carotene-linoleic acid coupled oxidation. It is reasonable to assume that the antioxidant activity of the investigated compounds could contribute to their previously proven biological properties as cytostatic and antiviral agents.
European Journal of Pharmaceutical Sciences | 2002
Anita Martinac; Jelena Filipović-Grčić; Monika Barbarić; Branka Zorc; Dario Voinovich; Ivan Jalšenjak
The purpose of this study was to evaluate and compare the ability of the macromolecular conjugates and microspheres to modify the release rate of gemfibrozil (Gem). Gem was covalently linked to two similar polymers: poly[alpha,beta-(N-2-hydroxyethyl-DL-aspartamide)] (PHEA) and poly[alpha,beta-(N-3-hydroxypropyl-DL-aspartamide)] (PHPA) by an ester linkage. The polymer-drug conjugates obtained (PHEA-G(1-3) and PHPA-G) differ in weight-average molecular weight, length of spacer and Gem content. Microspheres, composed of chitosans of different molecular weight alone or as a mixture with (2-hydroxypropyl)methylcellulose (HPMC), PHEA or PHPA and with different theoretical polymer/drug ratio (2:1 and 3:1, w/w) were prepared by spray drying. The microparticulate systems were morphologically characterised by scanning electron microscopy, particle size analysis and Gem content was determined. In vitro dissolution tests were performed to evaluate the feasibility of conjugates and microspheres in modulating Gem release. The results obtained show that microspheres are always suitable to modulate Gem release and that the best conditions are achieved by microspheres composed of the low molecular weight chitosan (CL) combined with PHPA or HPMC with either 2:1 or 3:1 (w/w) polymer/drug ratio. The PHEA-G conjugates exhibited rapid Gem release within less than 2 h, while the PHPA-G conjugate showed sustained Gem release profiles over a 10-h period.
European Journal of Medicinal Chemistry | 2007
Monika Barbarić; Marijeta Kralj; Marko Marjanović; Ivana Husnjak; Krešimir Pavelić; Jelena Filipović-Grčić; Davor Zorc; Branka Zorc
Journal of Medicinal Chemistry | 2005
Ninoslav Opacic; Monika Barbarić; Branka Zorc; Mario Cetina; Ante Nagl; Danijel Frkovic; Marijeta Kralj; Krešimir Pavelić; Jan Balzarini; Graciela Andrei; Robert Snoeck; Erik De Clercq; Silvana Raić-Malić; Mladen Mintas
Journal of Medicinal Chemistry | 2005
Monika Barbarić; Stanko Uršić; Viktor Pilepić; Branka Zorc; Antonija Hergold-Brundić; Ante Nagl; Mira Grdiša; Krešimir Pavelić; Robert Snoeck; Graciela Andrei; Jan Balzarini; Erik De Clercq; Mladen Mintas
Acta Pharmaceutica | 2003
Monika Barbarić; Sandra Kraljević; Magdalena Grce; Branka Zorc
Acta Pharmaceutica | 2005
Marijana Zovko; Monika Barbarić; Branka Zorc; Anita Hafner; Jelena Filipović-Grčić
The Lancet | 2011
Monika Barbarić; Katarina Mišković; Mirza Bojić; Mirela Baus Lončar; Asja Smolčić-Bubalo; Zeljko Debeljak; Marica Medić-Šarić
Farmaceutski glasnik | 2005
Koraljka Hrs; Monika Barbarić; Branka Zorc